The Use of Extracts of Goldenrod (Solidago Virgaurea L.) for the Treatment of Diseases of the Urinary Tract
Journal Title: Нирки - Year 2014, Vol 3, Issue 9
Abstract
This review examines the pharmacological and clinical data on the use of extracts of goldenrod (Solidago virgaurea L.) for the treatment of diseases of the urinary system. Goldenrod extracts exhibit 6 major pharmacological effects: anti-bacterial, anti-inflammatory, immunomodulatory, antispasmodic, analgesic and diuretic. Results of open non-randomized studies have shown the possibility of using extracts of goldenrod for the treatment of infectious (cystitis) and functional (irritable bladder) urinary tract diseases. Evaluating the effectiveness of the treatment as «good» and «very good», which gave doctors and patients at the end of therapy, reached 90–100% level. For the manifestation of the therapeutic effect of the drug it was enough to take it 2–4 weeks. Side effects were rare — in larger studies, their frequency did not exceed 0.3% and they were of mild severity and were limited mainly to gastro-intestinal disorders and allergic reactions. Overall, treatment was well tolerated. Conclusions. Extracts of goldenrod (Solidago virgaurea L.) can be used in the complex therapy of diseases of the urinary tract to increase the effectiveness of therapy, to accelerate the recovery of patients and to reduce the likelihood of relapses.
Authors and Affiliations
A. V. Savustyanenko
Keywords
Related Articles
- EP ID EP225247
- DOI -
- Views 104
- Downloads 0
The Use of Extracts of Goldenrod (Solidago Virgaurea L.) for the Treatment of Diseases of the Urinary Tract
This review examines the pharmacological and clinical data on the use of extracts of goldenrod (Solidago virgaurea L.) for the treatment of diseases of the urinary system. Goldenrod extracts exhibit 6 major pharmacologic...
The Experience of Combination Phytotherapy in Patients with Urethrolithiasis
In the article the attention was paid to one of the most urgent problems of modern medicine — urolithiasis. One component of the pharmacotherapy of this disease is phytotherapy. This article provides an experience of use...
Kidney damage in some rheumatic diseases
Rheumatic disease with visceral manifestations pose a potential problem for the disease course and its prognosis. Such visceral manifestations may include kidney damage or complications, particularly in certain cases bon...
Diagnostic Role of N-Acetyl-β-D-Glucosaminidase as an Early Marker of Kidney Damage
In many diseases of the kidneys, N-acetyl-β-D-glucosaminidase (NAG) in the urine is excreted in large quantities. A significant increase in NAG activity is observed at the primary and secondary kidney damage, heavy metal...
Hypomagnesemia in Chronic Kidney Disease Stage 5
The article describes the clinical case of correction of hypomagnesemia in a patient 49 years with chronic kidney disease stage 5 with application magnesium orotate.